STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $19,000 | -54.8% | 3,938 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $42,000 | +27.3% | 3,938 | +24.9% | 0.00% | 0.0% |
| Q3 2019 | $33,000 | -31.2% | 3,153 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $48,000 | +17.1% | 3,153 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $41,000 | +127.8% | 3,153 | +63.4% | 0.00% | +100.0% |
| Q4 2018 | $18,000 | -43.8% | 1,930 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $32,000 | +3.2% | 1,930 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $31,000 | +3.3% | 1,930 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $30,000 | 0.0% | 1,930 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $30,000 | +172.7% | 1,930 | +47.0% | 0.00% | 0.0% |
| Q3 2017 | $11,000 | -8.3% | 1,313 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $12,000 | +9.1% | 1,313 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $11,000 | – | 1,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |